Short chains of amino acids can form drug delivery nanoparticles and boost the properties of potential medicines ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Terrain Biosciences launches from stealth today as the world's first RNA design-build company, using advanced AI and its ...

AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

PureTech Founded Entity Seaport Therapeutics Announces Publication of New Research Demonstrating Increased Lymphatic Transport with Glyph Platform ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...

A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.